The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581
Alternative splicing: increasing diversity in the proteomic world
Graveley, B. R. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(00)02176-4 · Cited by 1,221
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H., Manoharan, M., & Levin, A. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 288
Self-citationZhang, H., Cook, J., Nickel, J., Yu, R., Stecker, K., Myers, K., & Dean, N. M. (2000) · Nature Biotechnology · doi:10.1038/78475 · Cited by 268
Pharmacokinetics of Antisense Oligonucleotides
Agrawal, S., Temsamani, J., Galbraith, W., & Tang, J. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528010-00002 · Cited by 261
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1083 · Cited by 255
Self-citationAntisense Oligonucleotides: Promise and Reality
Lebedeva, I., & Stein, C. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.403 · Cited by 236
Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides
Sierakowska, H., Sambade, M. J., Agrawal, S., & Kole, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12840 · Cited by 236
Self-citationAntisense therapy in oncology: new hope for an old idea?
Tamm, I., Dörken, B., & Hartmann, G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05629-x · Cited by 229
Wilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 217
Self-citationNuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs
Sazani, P., Kang, S.-H., Maier, M. A., Wei, C., Dillman, J., Summerton, J., Manoharan, M., & Kole, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.19.3965 · Cited by 212
Self-citationTaylor, J. K., Zhang, Q. Q., Wyatt, J. R., & Dean, N. M. (1999) · Nature Biotechnology · doi:10.1038/15079 · Cited by 197
Morpholino antisense oligonucleotides: tools for investigating vertebrate development.
Corey, D. R., & Abrams, J. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reviews1015 · Cited by 188
Friedman, K. J., Kole, J., Cohn, J. A., Knowles, M. R., Silverman, L. M., & Kole, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36193 · Cited by 166
Self-citationModification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells
Mercatante, D. R., Bortner, C. D., Cidlowski, J. A., & Kole, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009256200 · Cited by 163
Self-citationJuliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 160
Self-citationLacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., & Kole, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9591 · Cited by 159
Self-citationKalbfuss, B., Mabon, S. A., & Misteli, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105113200 · Cited by 116
Pharmacokinetics and Tissue Distribution of a Peptide Nucleic Acid After Intravenous Administration
McMahon, B. M., Mays, D. C., Lipsky, J. J., Stewart, J. A., Fauq, A. H., & Richelson, E. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070803 · Cited by 106
Arora, V., Knapp, D. C., Reddy, M. T., Weller, D. D., & Iversen, P. L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10088 · Cited by 79
Suwanmanee, T., Sierakowska, H., Lacerra, G., Svasti, S., Kirby, S. L., Walsh, C., Fucharoen, S., & Kole, R. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.545 · Cited by 66
Self-citationMehta, R., Stecker, K., Cooper, S. R., Templin, M. V., Tsai, Y.-L., Condon, T. P., Bennett, C. F., & Hardee, G. E. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00143.x · Cited by 55
Mercatante, D. R., Sazani, P., & Kole, R. (2001) · Current Cancer Drug Targets · doi:10.2174/1568009013334124 · Cited by 52
Self-citationGeary, R. S., Khatsenko, O. G., Bunker, K., Crooke, R. M., Moore, M., Burckin, T., Truong, L., Sasmor, H. M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38832-9 · Cited by 49
Preclinical and Clinical Pharmacology of Antisense Oligonucleotides
Marcusson, E. G., Yacyshyn, B., Shanahan, W. R., & Dean, N. M. (1999) · Molecular Biotechnology · doi:10.1385/mb:12:1:1 · Cited by 34
Transdermal delivery of antisense compounds
Brand, R. M., & Iversen, P. L. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00083-1 · Cited by 32
Cited by
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Self-citationAntisense technologies: Improvement through novel chemical modifications
Kurreck, J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03555.x · Cited by 1,006
Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70211-x · Cited by 653
Self-citationChallenging the dogma: the hidden layer of non‐protein‐coding RNAs in complex organisms
Mattick, J. S. (2003) · BioEssays · doi:10.1002/bies.10332 · Cited by 570
Metadata
- Authors
- Sazani, P., Gemignani, F., Kang, S.-H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., & Kole, R.
- Venue
- Nature Biotechnology
- Published
- 2002-11-11
- Volume
- 20
- Issue
- 12
- Pages
- 1228-1233
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2003066928
- Cited by
- 301
- References
- 29
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.